Budapest-based pharmaceutical giant Gedeon Richter Plc. announced its Q4/FY 2024 financial results at the website of the Budapest Stock Exchange by stating that 2024 was an active year with business development across all segments, aimed at providing access to health by bringing solutions to unmet needs and by offering affordable medicines to a wide range […]
Hungary's Goodwill Pharma Plc. has expanded its warehouse capacity, built a research and development and innovation laboratory, a new head office and a pharmaceutical manufacturing plant in Szeged, Hungary, the almost HUF 5 billion investment was handed over on Thursday. Ferenc Jójárt, CEO of the Szeged-based company, said at the ceremony that Goodwill Pharma is […]
Gedeon Richter has announced positive topline results from Phase I and Phase III clinical studies for its proposed biosimilar to RoActemra® tocilizumab that has the development code 'RGB-19'. The Hungarian pharmaceutical firm points out in a statement on the webiste of the Budapest Stock Exchange that Phase I clinical study evaluated the equivalence of pharmacokinetics […]
Egis Pharmaceuticals Plc. has acquired one of Teva Pharmaceuticals Plc.'s well-known product family for skin application, following the approval of the competition authority, the pharmaceutical manufacturer informed MTI on Monday. According to the statement, the takeover of the distribution and promotion of the product line began on December 17, 2024, and the parties sought to […]
Gedeon Richter Plc. and Hikma Pharmaceuticals Plc. has announced that the U.S. Food and Drug Administration (FDA) had accepted for review the Biologics License Applications (BLA) for RGB-14, a Denosumab biosimilar candidate comprising two biosimilar products referencing Prolia® and Xgeva®, a human monoclonal antibody for the treatment of osteoporosis and fractures due to bone metastasis, […]
As part of its commitment to expanding its presence in Hungary, global animal vaccine producer Ceva-Phylaxia has announced an EUR 75 million investment, establishing a state-of-the-art unit in Monor dedicated to manufacturing inactivated, multicomponent vaccines, the Hungarian Investment Promotion Agency (HIPA) reports. Following the official groundbreaking ceremony for the 7,000-square-meter facility, production is expected to […]
The pharma companies AbbVie (headquartered in North Chicago, Illinois in the United States) and Gedeon Richter Plc. (headquartered in Budapest, Hungary) have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. A statement on the website of the Budapest Stock Exchange highlights that this collaboration […]
The new headquarters of Richter Plc. in Kőbánya, the 10th district of the Hungarian capital was inaugurated on Thursday. The 17,400-square-meter building, which provides space for 450 employees, was completed with an investment of HUF 20 billion, financed by the pharmaceutical company from its own resources. Speaking at the opening ceremony, Energy Minister Csaba Lantos […]
The consolidated sales revenue of the pharmaceutical company Gedeon Richter Plc. was HUF 203.4 billion in the first quarter of 2024, 3.0% lower than a year earlier, the pharmaceutical company announced on the website of the Budapest Stock Exchange (BSE) on Tuesday. Analysts had expected revenues to fall 3.6% to HUF 202 billion. In the […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals SA. In the statement, Richter confirms that it has participated in the monetisation process of Mithra, which was publicly initiated by […]
The pharmaceutical company Sanofi launched its international program "Cancer & Work: Acting Together" in February. It provides support to employees affected by cancer. The company says in a statement that it is providing social, mental and financial support, with up to twelve months of supplementary pay through a health fund, regardless of job title or […]
Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has signed an agreement with HELM AG, a Germany-based stock corporation (“HELM”) to buy 50% stake in Richter-Helm BioTec GmbH & Co. KG (“RHT”); and 30% stake in Richter-Helm BioLogics GmbH & Co. KG. (“RHB”) to become 100% owner of […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it expanded its partnership with Mithra Pharmaceuticals SA with a binding Head of Terms (HoT) agreement for the development and commercialization of the first estetrolbased combined oral contraceptive (15 mg estetrol (E4) / 3 mg drospirenone) and […]
With an investment of HUF 6.2 billion, the most modern pharmaceutical wholesale warehouse in Central and Eastern Europe has been built on 3,000 square meters as the automated high-bay warehouse of Hungaropharma Plc. has been inaugurated The third stage of Hungaropharma's Budapest Logistics Center is not only suitable for the logistics of its own stocks […]
The Swiss multinational healthcare company Roche, one of the largest pharmaceutical companies in the world by revenue and the leading provider of cancer treatments globally, has diversified activities in Hungary: the pharmaceutical, diagnostics and diabetes divisions and the Roche Service&Solution Center employ over 2,000 people altogether. General Manager Raffaella Claudia Bondi, who has been at […]
